Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:34 PM ET Form 4
Insider Buying Lyell Immunopharma, Inc. LYEL

Lyell Immunopharma Insider ARCH Venture Fund XIII L.P. Buys $25M of Stock

ARCH Venture Fund XIII L.P. bought 2,321,262 shares of Lyell Immunopharma, Inc. at $10.77 a share, worth $25M in total on Nov 4, 2026. Shares held after the trade: 3,747,790 (+162.7%).

Value
$25M
Shares
2,321,262
Price
$10.77
Holding change
+162.7%
Trade date
Nov 4, 2026
5:34 PM ET Form 4
Insider Selling Globus Medical Inc GMED

Globus Medical Director Ann D. Rhoads Sells $425K of Stock

Ann D. Rhoads, Director, sold 5,000 shares of Globus Medical Inc at $85.00 a share, worth $425K in total on Nov 4, 2026. Shares held after the trade: 35,384 (-12.4%).

Value
$425K
Shares
5,000
Price
$85.00
Role
Director
Holding change
-12.4%
Trade date
Nov 4, 2026
5:30 PM ET Form 4
Insider Selling Bloom Energy Corp BE

Bloom Energy Director Barbara J. Burger Sells $502K of Stock

Barbara J. Burger, Director, sold 2,333 shares of Bloom Energy Corp at $215.05 a share, worth $502K in total on Nov 3, 2026. Shares held after the trade: 36,607 (-6.0%).

Value
$502K
Shares
2,333
Price
$215.05
Role
Director
Holding change
-6.0%
Trade date
Nov 3, 2026
5:28 PM ET 8-K
Capital Raise Banzai International, Inc. PARA

Parabolic Technologies Capital Raise of $13.5M

Parabolic Technologies, Inc. closed a firm commitment underwritten public offering of 4,963,235 units at a price of $2.72 per unit, generating gross proceeds of approximately $13.5 million. Each unit consists of one share of Class A common stock (or a pre-funded warrant) and two warrants with an initial exercise price of $6.80. The company intends to use the net proceeds for working capital, general corporate purposes, and debt repayment.

Value
$13.5M
Counterparty
Aegis Capital Corp.
5:28 PM ET Form 4
Insider Selling Arhaus, Inc. ARHS

Arhaus Insider 2018 Reed Dynasty Trust Sells $1.62M of Stock

2018 Reed Dynasty Trust sold 127,965 shares of Arhaus, Inc. at $12.02 to $13.03 a share (average $12.63) in 2 transactions, worth $1.62M in total between Nov 3, 2026 and Nov 4, 2026. Shares held after the trade: 64,927 (-54.5%).

Value
$1.62M
Shares
127,965
Average price
$12.63
Holding change
-54.5%
Trade date
Nov 3, 2026 to Nov 4, 2026
5:28 PM ET Form 4
Insider Selling Arhaus, Inc. ARHS

Arhaus CEO and Chairman John P. Reed Sells $1.86M of Stock

John P. Reed, CEO and Chairman, sold 147,431 shares of Arhaus, Inc. at $12.02 to $13.03 a share (average $12.63) in 2 transactions, worth $1.86M in total between Nov 3, 2026 and Nov 4, 2026. Shares held after the trade: 115,799 (-43.6%).

Value
$1.86M
Shares
147,431
Average price
$12.63
Role
CEO and Chairman
Holding change
-43.6%
Trade date
Nov 3, 2026 to Nov 4, 2026
5:27 PM ET Form 4
Insider Selling PC Connection Inc CNXN

PC Connection Chairman & Chief Admin Officer Patricia Gallup Sells $1.25M of Stock

Patricia Gallup, Chairman & Chief Admin Officer, sold 14,182 shares of PC Connection Inc at $86.67 to $88.60 a share (average $88.03) in 4 transactions, worth $1.25M in total between Nov 3, 2026 and Nov 4, 2026. Shares held after the trade: 6,885,009 (-0.1%).

Value
$1.25M
Shares
14,182
Average price
$88.03
Role
Chairman & Chief Admin Officer
Holding change
-0.1%
Trade date
Nov 3, 2026 to Nov 4, 2026
5:27 PM ET 8-K
Financial Results Avalanche Treasury Corp AVAT

Avalanche Treasury Financial Results

Avalanche Treasury Corp reported preliminary Q3 2026 results, including net income of $54.6 million and $60 million in gains from its AVAX token holdings. The company also announced it repurchased approximately 8% of its outstanding Class A shares for $3.3 million and fully repaid its FalconX collateralized loan.

Term
Q3 2026

“Buying back our stock below the value of our AVAX holdings is one of the most direct ways we can create value for shareholders. Removing roughly 8% of our outstanding share count while also eliminating our FalconX loan shows the discipline we bring to managing this treasury.”

Bart Smith, CEO of AVAT
5:27 PM ET Form 4
Insider Buying Coursera, Inc. COUR

Coursera Insider Pale Fire Capital SE Buys $31.5M of Stock

Pale Fire Capital SE bought 8,355,251 shares of Coursera, Inc. at $3.72 to $3.85 a share (average $3.76) in 3 transactions, worth $31.5M in total between Nov 3, 2026 and Nov 5, 2026. Shares held after the trade: 37,161,666 (+9.2%).

Value
$31.5M
Shares
8,355,251
Average price
$3.76
Holding change
+9.2%
Trade date
Nov 3, 2026 to Nov 5, 2026
5:25 PM ET 8-K
Capital Raise Annovis Bio, Inc. ANVS

Annovis Bio Capital Raise of $21M

Annovis Bio entered into an underwriting agreement to raise approximately $21.0 million through a public offering of 19,000,000 shares of common stock and 2,000,000 pre-funded warrants, accompanied by warrants to purchase an additional 21,000,000 shares. The company intends to use the proceeds for the clinical development of its lead compound, Buntanetap, in studies for Alzheimer’s and Parkinson’s disease.

Value
$21M
Counterparty
Canaccord Genuity LLC
5:25 PM ET Form 4
Insider Buying Liberty Energy Inc. LBRT

Liberty Energy CAO Ryan T. Gosney Buys $45K of Stock

Ryan T. Gosney, CAO, bought 3,000 shares of Liberty Energy Inc. at $15.00 a share, worth $45K in total on Nov 3, 2026. Shares held after the trade: 236,327 (+1.3%).

Value
$45K
Shares
3,000
Price
$15.00
Role
CAO
Holding change
+1.3%
Trade date
Nov 3, 2026
5:25 PM ET 10-Q
Financial Results Revelation Biosciences, Inc. REVB

Revelation Biosciences Q3 2026 Results: Net Loss of $3.32M, Loss Widens

Revelation Biosciences reported a net loss of $9.6 million for the nine months ended September 30, 2026, compared to $6.4 million in the prior year, driven by increased R&D and G&A expenses. The company maintains a cash balance of $9.1 million and expressed substantial doubt about its ability to continue as a going concern without additional capital.

Key figure
Net loss $3.32M
5:25 PM ET Form 4
Insider Buying Liberty Energy Inc. LBRT

Liberty Energy CEO and President Ron Gusek Buys $377K of Stock

Ron Gusek, CEO and President, bought 25,000 shares of Liberty Energy Inc. at $15.09 a share, worth $377K in total on Nov 3, 2026. Shares held after the trade: 1,068,702 (+2.4%).

Value
$377K
Shares
25,000
Price
$15.09
Role
CEO and President
Holding change
+2.4%
Trade date
Nov 3, 2026
5:24 PM ET 8-K
Leadership Change Algorhythm Holdings, Inc. RIME

Algorhythm Holdings Leadership Change

Algorhythm Holdings announced that Andrew Thompson resigned as CEO and Chairman, effective October 30, 2026. Gregory D. Smith, a current board member and former IBM executive, was appointed as the new CEO and Chairman effective November 2, 2026. Mr. Smith's employment agreement includes an annual base salary of $375,000 and an initial grant of approximately 2.1 million restricted shares.

Term
2 years
5:24 PM ET 8-K
Leadership Change Datavault AI Inc. DVLT

Datavault AI Leadership Change

Datavault AI Inc. has terminated Nathaniel Bradley from his roles as Chief Executive Officer and President, effective November 1, 2026. The decision was approved by all board members except Mr. Bradley, who remains a member of the Board of Directors.

5:23 PM ET 8-K
Financial Results Mount Logan Capital Inc. MLCI

Mount Logan Capital Financial Results

Mount Logan Capital Inc. reported its third quarter 2026 financial results, highlighting year-to-date Segment Income of $11.5 million, up 21% year-over-year. The company completed two strategic transactions during the quarter expected to add $6.5 million in annualized run-rate Fee-Related Earnings and launched its initial suite of MYGA products under the ReliAbility brand.

Term
Q3 2026

“Our third quarter results reflect continued stability in our insurance business and year-to-date growth in Segment Income, even before the benefits of our recent strategic initiatives begin to contribute meaningfully to earnings. With the Yieldstreet and ACIF transactions completed, the proposed AFA transaction pending, and further opportunities ahead in asset management and insurance, we expect to see improving financial performance beginning in the fourth quarter and building through 2027.”

Ted Goldthorpe, Chief Executive Officer and Chairman of Mount Logan
5:23 PM ET Form 4
Insider Buying Mexico Equity & Income Fund Inc MXE

Mexico Equity & Income Fund Insider Saba Capital Management L.P. Buys $314K of Stock

Saba Capital Management L.P. bought 15,011 shares of Mexico Equity & Income Fund Inc at $20.95 a share, worth $314K in total on Nov 4, 2026. Shares held after the trade: 2,493,840 (+0.6%).

Value
$314K
Shares
15,011
Price
$20.95
Holding change
+0.6%
Trade date
Nov 4, 2026
5:23 PM ET 8-K
Loan & Debt Public Policy Holding Company, Inc. PPHC

Public Policy Holding Company $105M Debt Financing with Bank of America, N.A.

Public Policy Holding Company (PPHC) entered into a new $105 million senior secured credit facility with Bank of America, consisting of a $65 million term loan and a $40 million revolver. The proceeds will be used to refinance existing debt and fund the acquisition of Reevemark LLC, with plans to syndicate the facility up to $150 million by January 2027.

Value
$105M
Counterparty
Bank of America, N.A.
Term
5 years
5:23 PM ET 10-Q
Financial Results Profound Medical Corp. PROF

Profound Medical Q3 2026 Results: Net Loss of $7.72M, Loss Narrows

For the nine months ended September 30, 2026, Profound Medical Corp. reported total revenue of $17.65 million, a significant increase from $10.12 million in the prior year, driven largely by capital equipment sales. Despite the revenue growth, the company recorded a net loss of $24.32 million, though this was an improvement over the $34.40 million loss in the same period of 2025.

Key figure
Net loss $7.72M
5:23 PM ET 10-Q
Financial Results Acacia Research Corp ACTG ▶ Call

Acacia Research Q3 2026 Results: Net Loss of $5.56M, Loss Widens

Acacia Research Corporation reported 97,593,766 shares of common stock outstanding as of November 2, 2026. The balance sheet shows a cash position of $336.9 million as of September 30, 2026, with significant assets held in oil and natural gas properties ($198.1 million) and a decrease in equity method investments from $30.9 million to zero during the period.

Key figure
Net loss $5.56M
5:23 PM ET 10-Q
Financial Results Savers Value Village, Inc. SVV

Savers Value Village Q3 2026 Results: Turns Profitable, Net Income $23.4M

Savers Value Village reported net sales of $463.1 million for the thirteen weeks ended October 3, 2026, a 8.5% increase over the prior year period. The company achieved net income of $23.4 million compared to a net loss of $14.0 million in the prior year, driven by higher operating income and lower debt extinguishment costs.

Key figure
Net income $23.4M
5:22 PM ET Form 4
Insider Selling F5, Inc. FFIV

F5 Chief Technology Ops Officer Michael F. Montoya Sells $428K of Stock

Michael F. Montoya, Chief Technology Ops Officer, sold 1,297 shares of F5, Inc. at $327.23 to $336.65 a share (average $329.68) in 7 transactions, worth $428K in total on Nov 4, 2026. Shares held after the trade: 1,309 (-3.0%).

Value
$428K
Shares
1,297
Average price
$329.68
Role
Chief Technology Ops Officer
Holding change
-3.0%
Trade date
Nov 4, 2026
5:22 PM ET 10-Q
Financial Results Sandridge Energy Inc SD

Sandridge Energy Q3 2026 Results: Net Income $30.6M, Up 91.9% YoY

SandRidge Energy reported a significant increase in net income to $75.98 million for the nine months ended September 30, 2026, compared to $48.56 million in the prior year, driven by higher oil and natural gas revenues. The company also recognized a $14.2 million income tax benefit and significantly increased its capital expenditures and asset acquisitions during the period.

Key figure
Net income $30.6M · +91.9% YoY
5:22 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $1.05M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 1,723 shares of United Therapeutics Corp at $610.29 to $613.13 a share (average $611.06) in 4 transactions, worth $1.05M in total on Nov 4, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$1.05M
Shares
1,723
Average price
$611.06
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Nov 4, 2026
5:21 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $4.66M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 7,777 shares of United Therapeutics Corp at $580.70 to $609.09 a share (average $599.64) in 24 transactions, worth $4.66M in total on Nov 4, 2026. Shares held after the trade: 326,166 (-0.4%).

Value
$4.66M
Shares
7,777
Average price
$599.64
Role
Chairperson & CEO
Holding change
-0.4%
Trade date
Nov 4, 2026
5:21 PM ET 10-Q
Financial Results Surf Air Mobility Inc. SRFM ▶ Call

Surf Air Mobility Q3 2026 Results: Net Loss of $20.4M, Loss Narrows

Surf Air Mobility reported a net loss of $68.8 million for the nine months ended September 30, 2026, a slight improvement from the $73.7 million loss in the prior year period. Revenue grew 14.3% year-over-year to $91.6 million, while the company significantly increased its common stock outstanding from 73.1 million to 134.9 million shares to fund operations and settle obligations.

Key figure
Net loss $20.4M
5:21 PM ET 10-Q
Financial Results iRhythm Holdings, Inc. IRTC

iRhythm Holdings Q3 2026 Results: Net Loss of $29.9M, Loss Widens

For the nine months ended September 30, 2026, iRhythm reported revenue of $645.2 million, a 19.9% increase over the prior year, though it incurred a net loss from operations of $51.3 million. Financial results were significantly impacted by $63.7 million in litigation settlements and an acquisition of Vital Connect, Inc. mentioned in forward-looking statements.

Key figure
Net loss $29.9M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.